Cargando…

A practical approach to pharmaceutical policy /

Pharmaceuticals are an essential component of health care. But for many people in low- and middle-income countries, access to the medicines they need to prevent or treat severe illnesses is limited. Typical problems are lack of availability, costs that exceed the individual's purchasing power o...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Seiter, Andreas
Autor Corporativo: World Bank
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, DC : World Bank, ©2010.
Colección:Directions in development (Washington, D.C.)
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a22000004a 4500
001 EBOOKCENTRAL_ocn659558279
003 OCoLC
005 20240329122006.0
006 m o d
007 cr |n|||||||||
008 100409s2010 dcua ob 001 0 eng c
010 |a  2010015420 
040 |a COO  |b eng  |e pn  |c COO  |d N$T  |d CDX  |d YDXCP  |d E7B  |d OCLCQ  |d MERUC  |d OCLCQ  |d FVL  |d OCLCQ  |d CUS  |d OCLCQ  |d OCLCA  |d OCLCF  |d DEBSZ  |d P4I  |d OCLCQ  |d NLGGC  |d BWS  |d MHW  |d MEAUC  |d IDEBK  |d AU@  |d OCLCQ  |d AZK  |d COCUF  |d PIFAG  |d DCWBL  |d OCLCQ  |d VGM  |d OCLCO  |d ZCU  |d OCLCO  |d MERER  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d RRP  |d OCLCA  |d U3W  |d OCLCA  |d CAUOI  |d OCLCO  |d OCLCQ  |d STF  |d WRM  |d CEF  |d NRAMU  |d OCLCE  |d ICG  |d VT2  |d OCLCQ  |d WYU  |d OCLCA  |d OCLCQ  |d OCLCA  |d CUY  |d OCLCQ  |d DKC  |d OCLCQ  |d TKN  |d UX1  |d HS0  |d UWK  |d ADU  |d YOU  |d OCLCA  |d UKCRE  |d OCLCQ  |d REDDC  |d OCLCQ  |d OCLCO  |d OCLCQ  |d SFB  |d SMC  |d OCLCO  |d OCLCL 
016 7 |a 101528354  |2 DNLM 
019 |a 663077596  |a 707211797  |a 729016498  |a 748606680  |a 811493041  |a 813532974  |a 816573718  |a 821630878  |a 827879250  |a 894042208  |a 961490500  |a 962652844  |a 992279687  |a 993931421  |a 1029484961  |a 1044743396  |a 1045557167  |a 1055322610  |a 1058207395  |a 1062857909  |a 1081201579  |a 1088989716  |a 1091078611  |a 1109046972  |a 1110265611  |a 1112811814  |a 1119035435  |a 1120875728  |a 1153495211  |a 1162431820  |a 1202562858  |a 1228572748  |a 1257341152  |a 1288255529  |a 1300799990  |a 1377820893  |a 1397506774 
020 |a 9780821383865  |q (alk. paper) 
020 |a 0821383868  |q (alk. paper) 
020 |a 9780821383872  |q (electronic bk.) 
020 |a 0821383876  |q (electronic bk.) 
020 |a 1282725645 
020 |a 9781282725645 
020 |a 6612725648 
020 |a 9786612725647 
024 8 |a 9786612725647 
029 1 |a AU@  |b 000049071277 
029 1 |a AU@  |b 000053262374 
029 1 |a DEBBG  |b BV044147307 
029 1 |a DEBSZ  |b 396433685 
029 1 |a NZ1  |b 13649044 
029 1 |a NZ1  |b 14220950 
035 |a (OCoLC)659558279  |z (OCoLC)663077596  |z (OCoLC)707211797  |z (OCoLC)729016498  |z (OCoLC)748606680  |z (OCoLC)811493041  |z (OCoLC)813532974  |z (OCoLC)816573718  |z (OCoLC)821630878  |z (OCoLC)827879250  |z (OCoLC)894042208  |z (OCoLC)961490500  |z (OCoLC)962652844  |z (OCoLC)992279687  |z (OCoLC)993931421  |z (OCoLC)1029484961  |z (OCoLC)1044743396  |z (OCoLC)1045557167  |z (OCoLC)1055322610  |z (OCoLC)1058207395  |z (OCoLC)1062857909  |z (OCoLC)1081201579  |z (OCoLC)1088989716  |z (OCoLC)1091078611  |z (OCoLC)1109046972  |z (OCoLC)1110265611  |z (OCoLC)1112811814  |z (OCoLC)1119035435  |z (OCoLC)1120875728  |z (OCoLC)1153495211  |z (OCoLC)1162431820  |z (OCoLC)1202562858  |z (OCoLC)1228572748  |z (OCoLC)1257341152  |z (OCoLC)1288255529  |z (OCoLC)1300799990  |z (OCoLC)1377820893  |z (OCoLC)1397506774 
037 |a 272564  |b MIL 
042 |a pcc  |a dlr 
043 |a dd----- 
050 4 |a RA401.A1  |b S45 2010 
055 5 |a RA* 
060 4 |a QV 736  |b S462p 2010 
072 7 |a MED  |x 003000  |2 bisacsh 
072 7 |a JP, MBP  |2 bicssc 
082 0 4 |a 362.17/82  |2 22 
049 |a UAMI 
100 1 |a Seiter, Andreas. 
245 1 2 |a A practical approach to pharmaceutical policy /  |c Andreas Seiter. 
260 |a Washington, DC :  |b World Bank,  |c ©2010. 
300 |a 1 online resource (xxi, 215 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file  |2 rda 
380 |a Bibliography 
490 1 |a Directions in development 
504 |a Includes bibliographical references and index. 
505 0 |a Pharmaceutical policy goals -- Introducing the stakeholders -- Patterns of dysfunction -- Key elements of a successful pharmaceutical policy -- Policy packages to achieve strategic long-term goals -- Factors influencing policy implementation -- Pharmaceutical policy illustrated in country examples -- Pharmaceutical policy outlook. 
520 |a Pharmaceuticals are an essential component of health care. But for many people in low- and middle-income countries, access to the medicines they need to prevent or treat severe illnesses is limited. Typical problems are lack of availability, costs that exceed the individual's purchasing power or lack of competent "agents"--Health workers that are well trained to give the correct advice on which medicines to take. Pharmaceutical policy is the part of health policy that aims at addressing these problems and increasing access to safe, effective and affordable medicines for all patients. There are many obstacles against achieving these goals. Such obstacles can arise from financial interests on the side of suppliers and health care providers, who may benefit from charging higher prices and issuing more prescriptions than might be justified from a clinical and economic viewpoint. Or from rogue suppliers trying to introduce low quality or counterfeit drugs into markets with less effective regulation. Also, corruption and ineffective bureaucracies sometimes interfere with well intended programs to offer access to essential medicines for the poor. This book offers policy makers a hands-on approach, tested in the World Bank's field work in many countries, for assessing the pharmaceutical sector, recognizing typical "patterns of dysfunction" and developing strategies to quickly deal with the most urgent problems while at the same time building a platform for sustainable long term policy. It offers examples from a variety of low- and middle income countries and provides practical assessment tools for policy makers. The book ends with the author's outlook on future developments in this complex policy field 
506 |3 Use copy  |f Restrictions unspecified  |2 star  |5 MiAaHDL 
533 |a Electronic reproduction.  |b [Place of publication not identified] :  |c HathiTrust Digital Library,  |d 2011.  |5 MiAaHDL 
538 |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.  |u http://purl.oclc.org/DLF/benchrepro0212  |5 MiAaHDL 
583 1 |a digitized  |c 2011  |h HathiTrust Digital Library  |l committed to preserve  |2 pda  |5 MiAaHDL 
546 |a English. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Pharmaceutical policy. 
650 1 2 |a Drug Industry  |x organization & administration 
650 2 2 |a Developed Countries 
650 2 2 |a Government Regulation 
650 2 2 |a Health Plan Implementation 
650 2 2 |a Health Policy  |x economics 
650 6 |a Médicaments  |x Politique gouvernementale. 
650 7 |a MEDICAL  |x Allied Health Services  |x General.  |2 bisacsh 
650 7 |a Pharmaceutical policy  |2 fast 
710 2 |a World Bank. 
758 |i has work:  |a A practical approach to pharmaceutical policy (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCYMp3y8t8CpQj7fxFBCHwd  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Seiter, Andreas.  |t Practical approach to pharmaceutical policy.  |d Washington, DC : World Bank, ©2010  |z 9780821383865  |w (DLC) 2010015420  |w (OCoLC)607465968 
776 0 8 |i Online version:  |a Seiter, Andreas.  |t Practical approach to pharmaceutical policy.  |d Washington, DC : World Bank, ©2010  |w (OCoLC)1288255529 
830 0 |a Directions in development (Washington, D.C.) 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=589825  |z Texto completo 
938 |a Coutts Information Services  |b COUT  |n 14702334 
938 |a ebrary  |b EBRY  |n ebr10408437 
938 |a EBSCOhost  |b EBSC  |n 332010 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n 272564 
938 |a YBP Library Services  |b YANK  |n 3440362 
994 |a 92  |b IZTAP